A WALL STREET JOURNAL ONLINE NEWS ROUNDUP
July 11, 2007 - General Electric Co. and Abbott Laboratories announced they have terminated GE's $8.13 billion deal to buy Abbott's primary in-vitro and point-of-care diagnostics businesses.

In separate statements, the companies said they were unable to agree on "final terms and conditions" of the proposed deal. As a result, according to GE's statement, the companies "agreed it was in the best interests of both companies to mutually terminate their agreement and discussions."

The Acuity steerable left ventricular lead device is designed for cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure. The product features a deflectable tip for precise placement of the lead even in difficult-to-access branch vessels on the left side of the heart, according to the company.

The Sensei Robotic Catheter System and Artisan Control Catheter facilitate manipulation, positioning and control of mapping catheters during EP procedures.

GE Healthcare introduced its ViewPoint Vascular comprehensive ultrasound data management solution for vascular labs at the Society of Vascular Surgeons (SVS)/Society of Vascular Ultrasound (SVU) annual meeting in Baltimore, MD.

Siemens has announced that syngo Circulation software is now available to use with its hybrid imaging scanners. The software provides a noninvasive cardiac evaluation in reportedly less than 10 minutes, and it will provide even more diagnostic information when conducting nuclear cardiac stress tests. It performs quantitative coronary assessment, left ventricular analysis, and it can fuse all of the data into a single report.

July 11, 2007 - CVRx Inc. chose a member of the configurable ARC 600 core family to drive its Rheos Baroreflex Hypertension Therapy System for its implantable blood pressure reduction device.
CVRx chose the ARC core for its very small size, ability to operate using extremely low power for deeply embedded organic applications.

July 11, 2007 - Baptist Cardiovascular Services launches a video interview with Cardiac Electrophysiologist Drew Pickett, M.D., on how implanting a defibrillator can help reduce sudden cardiac death, after a study sponsored by Medtronic Inc. and Wyeth shows that ICDs are a cost-effective therapy.

July 11, 2007- St. Jude Medical Inc. and the Duke Clinical Research Institute (DCRI) announced the first enrollment in a major study designed to better understand appropriate anti-clotting medication therapies for patients following implantation of tissue heart valves.

Medrad Inc. introduced the XDS, a new extravasation detector technology for the Stellant CT Injection System that, for the first time, directly senses extravasation pooling under the skin during a Computed Tomography (CT) procedure, this week at the American Healthcare Radiology Administrators (AHRA) Annual Meeting in Orlando, FL.

July 10, 2007 - CardioVations, a division of Ethicon Inc., a Johnson & Johnson Company, announced the launch of Port Access Precision Series, a new line of surgical instruments for use in minimally invasive valve repair procedures, designed to enhance precision, reliability and control in minimally invasive valve surgery.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now